Eli Lilly and Co
LLY
Company Profile
Business description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Contact
Lilly Corporate Center
Indianapolis IN 46285
USAT: +1 317 276-2000
E: jfletcher@lilly.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
43,000
Eli Lilly and Co News & Analysis
stocks
What broadening rally? AI stocks dominate US market again in Q2
Nvidia, Apple, and other major AI players drove market performance to an even greater degree in the quarter.
video
Will obesity drugs derail ResMed?
Morningstar analyst Shane Ponraj discusses the latest clinical trial results from Eli Lilly.
stocks
Obesity drug stocks: Why it will be ‘exceptionally difficult’ to dethrone Eli Lilly and Novo Nordisk
The two biggest players in the market appear poised to dominate for years to come.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,250.80 | 11.60 | -0.14% |
CAC 40 | 7,632.71 | 91.61 | -1.19% |
DAX 40 | 18,590.89 | 157.29 | -0.84% |
Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
FTSE 100 | 8,182.96 | 69.95 | -0.85% |
HKSE | 17,770.89 | 245.05 | -1.36% |
NASDAQ | 18,472.57 | 74.12 | 0.40% |
Nikkei 225 | 41,371.17 | 180.49 | 0.44% |
NZX 50 Index | 12,137.52 | 14.38 | 0.12% |
S&P 500 | 5,631.22 | 15.87 | 0.28% |
S&P/ASX 200 | 8,007.10 | 10.50 | -0.13% |
SSE Composite Index | 2,967.85 | 6.16 | -0.21% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Droneshield Ltd DRO | 1.93 | 0.67 | -25.77% |
Bellevue Gold Ltd BGL | 1.86 | 0.07 | -3.76% |
Red 5 Ltd RED | 0.42 | 0.00 | 0.60% |
Latin Resources Ltd LRS | 0.16 | 0.01 | -7.35% |
Zip Co Ltd ZIP | 1.60 | 0.03 | 1.59% |
Core Lithium Ltd CXO | 0.11 | 0.01 | -8.33% |
Australian Vanadium Ltd AVL | 0.02 | 0.00 | 3.13% |
Tabcorp Holdings Ltd TAH | 0.69 | 0.01 | -1.44% |
Liontown Resources Ltd LTR | 0.95 | 0.02 | -2.32% |
Mirvac Group MGR | 2.10 | 0.02 | 0.96% |